In connection with the start of the phase 3 trials of PCV21, Sanofi has expanded its alliance with South Korea-based SK Bio, ...

Pneumococcal pneumonia vaccine is under development for the treatment of pneumonia. It is a conjugate vaccine. It is administered through intramuscular as a liquid formulation. It is a new chemical ...

Sanofi and SK bioscience have entered into a new chapter of their collaboration in pneumococcal vaccines with an expanded agreement to develop, license and commercialize next-generation PCVs for both ...

Goldman Sachs analyst maintains Buy rating on Pfizer with $33 price target. Discusses update on 2nd-gen C. diff vaccine in ...

Healthcare professionals in the U.S. have noticed a significant increase in vaccine hesitancy among their patients, according ...

SK Bioscience, Sanofi collaborate on next-gen pneumococcal vaccine development SK Bioscience and Sanofi join forces to ...

Conner: Tell us about the new recommendations for the pneumonia vaccine.

Sanofi is handing SK bioscience 50 million euros ($52 million) as the longtime partners take their next-gen pneumococcal ...

Pneumonia is a lung infection that annually impacts millions of people around the globe, according to the Centers for Disease ...

French pharma major Sanofi says it has entered into a new chapter of the collaboration with South Korean firm SK bioscience ...

Under the new agreement, Sanofi will make an upfront ... "SK bioscience and Sanofi expand agreement for pneumococcal conjugate vaccines" was originally created and published by Pharmaceutical ...

INR:1273. pak vs new zealand live score The possibility of rapid detection of COVID-19 nucleic acid testing reagents may be hidden in these new meth ...